RANDAL S WEBER to Skin Neoplasms
This is a "connection" page, showing publications RANDAL S WEBER has written about Skin Neoplasms.
Connection Strength
1.491
-
Surgical management of non melanoma skin cancer of the head and neck. Oral Oncol. 2020 01; 100:104485.
Score: 0.224
-
Regarding ACR Appropriateness Criteria? aggressive nonmelanomatous skin cancer of the head and neck. Head Neck. 2016 Feb; 38(2):183.
Score: 0.171
-
A phase II study of gefitinib for aggressive cutaneous squamous cell carcinoma of the head and neck. Clin Cancer Res. 2012 Mar 01; 18(5):1435-46.
Score: 0.130
-
Craniofacial resection for nonmelanoma skin cancer of the head and neck. Laryngoscope. 2005 Jun; 115(6):931-7.
Score: 0.082
-
High-risk non-melanoma skin cancer of the head and neck. Curr Oncol Rep. 2005 Mar; 7(2):154-8.
Score: 0.080
-
Parotidectomy in the treatment of aggressive cutaneous malignancies. Arch Otolaryngol Head Neck Surg. 2002 May; 128(5):521-6.
Score: 0.066
-
Elective neck dissection versus observation in patients with head and neck cutaneous squamous cell carcinoma. Cancer. 2021 12 01; 127(23):4413-4420.
Score: 0.063
-
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck. Clin Cancer Res. 2021 08 15; 27(16):4557-4565.
Score: 0.062
-
Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck. Head Neck. 2021 05; 43(5):1592-1603.
Score: 0.061
-
Integrating depth of invasion in T classification improves the prognostic performance of the American Joint Committee on Cancer primary tumor staging system for cutaneous squamous cell carcinoma of the head and neck. Eur J Cancer. 2021 02; 144:169-177.
Score: 0.060
-
Inclusion of extranodal extension in the lymph node classification of cutaneous squamous cell carcinoma of the head and neck. Cancer. 2021 04 15; 127(8):1238-1245.
Score: 0.060
-
Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck. JAMA Otolaryngol Head Neck Surg. 2020 02 01; 146(2):128-135.
Score: 0.057
-
Nonmelanoma cutaneous cancers involving the skull base: outcomes of aggressive multimodal management. J Neurosurg. 2015 Sep; 123(3):781-8.
Score: 0.041
-
Cutaneous malignancy of the head and neck. Surg Oncol Clin N Am. 2015 Jul; 24(3):593-613.
Score: 0.041
-
Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res. 2014 Dec 15; 20(24):6582-92.
Score: 0.039
-
Two perplexing skin tumors: microcystic adnexal carcinoma and keratoacanthoma. Ann Otol Rhinol Laryngol. 1994 Oct; 103(10):829-32.
Score: 0.039
-
The role of adjuvant radiotherapy in the local management of desmoplastic melanoma. Cancer. 2014 May 01; 120(9):1361-8.
Score: 0.037
-
Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma. Head Neck. 2011 Feb; 33(2):189-98.
Score: 0.030
-
Advanced basal and squamous cell carcinomas of the skin of the head and neck. Cancer Treat Res. 1990; 52:61-81.
Score: 0.028
-
Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res. 2007 Nov 01; 13(21):6532-9.
Score: 0.024
-
4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of nonmelanoma skin cancer: a case-control analysis. J Invest Dermatol. 2007 Jan; 127(1):196-205.
Score: 0.022
-
In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst. 2005 Dec 21; 97(24):1822-31.
Score: 0.021
-
Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope. 2005 Sep; 115(9):1561-7.
Score: 0.021
-
p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization. Cancer Res. 1995 Aug 15; 55(16):3604-9.
Score: 0.010
-
Postoperative radiotherapy for cutaneous melanoma of the head and neck region. Int J Radiat Oncol Biol Phys. 1994 Nov 15; 30(4):795-8.
Score: 0.010
-
13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst. 1992 Feb 19; 84(4):235-41.
Score: 0.008
-
Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol. 2000 Dec; 157(6):1777-83.
Score: 0.004